| OZTA Stock | | | EUR 10.32 0.22 2.09% |
CFO
Alfredo Guerra is CFO VP of Grifols SA since 2014.
| Age | 65 |
| Tenure | 10 years |
| Phone | 34 93 571 02 21 |
| Web | https://www.grifols.com |
Grifols SA Management Efficiency
The company has return on total asset
(ROA) of
0.0155 % which means that it generated a profit of $0.0155 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity
(ROE) of
0.0182 %, meaning that it generated $0.0182 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities.
Grifols SA has accumulated 6.1
B in total debt with debt to equity ratio
(D/E) of 143.0, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Grifols SA has a current ratio of 2.63, suggesting that it is
liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Grifols SA until it has trouble settling it off, either with new capital or with free cash flow. So, Grifols SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Grifols SA sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Grifols to invest in growth at high rates of return. When we think about Grifols SA's use of debt, we should always consider it together with cash and equity.
Grifols, S.A., a specialty pharmaceutical company, develops, manufactures, and distributes a range of biological medicines on plasma derived proteins worldwide. The company was founded in 1940 and is headquartered in Barcelona, Spain. GRIFOLS SA operates under Drug Manufacturers - Major classification in Germany and is traded on Frankfurt Stock Exchange. It employs 22282 people. Grifols SA (OZTA) is traded on Frankfurt Exchange in Germany and employs 27,584 people.
Management Performance
Grifols SA Leadership Team
Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Nuria Lapea, Risk Treasury | |
| Maria Llano, Chief Officer | |
| M Tubau, Co Affairs | |
| Steven JD, Ex Chairman | |
| Mateo Humbert, Chief Human Resource Officer | |
| Montserrat Llamas, Chief Officer | |
| Vctor Deu, CoCEO Director | |
| Alfredo Guerra, CFO VP | |
| Raimon Roura, Co-CEO, Executive Director | |
| David Bell, Vice President of General Counsel of Grifols Shared Services North America Inc. | |
Grifols Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Currently Active Assets on Macroaxis
Other Information on Investing in Grifols Stock
Grifols SA financial ratios help investors to determine whether Grifols Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Grifols with respect to the benefits of owning Grifols SA security.